8% Off
HepaMerz150 mg+100
Mundipharma (BD) Pvt. Ltd.
৳165.60
Add to cart
Generic medicine
L-Ornithine L-Aspartate + Pancreatin: Brands, Price & Uses in Bangladesh
L-Ornithine L-Aspartate + Pancreatin is a combination product that pairs an ammonia-lowering amino-acid formulation with a pancreatic digestive enzyme concentrate.
About L-Ornithine L-Aspartate + Pancreatin
Indications of L-Ornithine L-Aspartate + Pancreatin
L-Ornithine L-Aspartate + Pancreatin is a combination product that pairs an ammonia-lowering amino-acid formulation with a pancreatic digestive enzyme concentrate. It is used in patients with chronic liver disease, particularly where impaired ammonia clearance and reduced digestive enzyme output occur together.
Established / Guideline-Supported Uses
- Hyperammonemia associated with liver disease — the L-ornithine L-aspartate component is used to lower elevated blood ammonia levels in patients with chronic liver disease and cirrhosis.
- Hepatic encephalopathy (supportive/adjunct treatment) — L-Ornithine L-Aspartate + Pancreatin is used as part of a broader treatment plan for latent and overt hepatic encephalopathy, always alongside other standard measures (e.g., lactulose, correction of precipitating factors) directed by a physician.
- Digestive enzyme replacement — the pancreatin component provides amylase, lipase, and protease to aid digestion of carbohydrates, fats, and proteins in patients with reduced pancreatic or digestive enzyme secretion, which is common in chronic liver and biliary disease.
Adjunct / Supportive Use
L-Ornithine L-Aspartate + Pancreatin is also used as a supportive measure for dyspepsia and maldigestion symptoms (bloating, early satiety, fatty food intolerance) that frequently accompany chronic liver disease, in conjunction with dietary and lifestyle measures.
L-Ornithine L-Aspartate + Pancreatin does not replace definitive treatment of the underlying liver disease and must be used under medical supervision.
Dosage & Administration of L-Ornithine L-Aspartate + Pancreatin
General Dosing Principles
The dose of L-Ornithine L-Aspartate + Pancreatin must be individualized by the treating physician based on the indication, severity of liver disease, and the specific product's strength. The information below reflects typical labeling patterns for combination products of this type; always follow the prescribing physician's instructions and the product package insert.
| Indication | Typical Adult Dosing |
|---|---|
| Hyperammonemia / hepatic encephalopathy (adjunct) | 1–2 tablets or 1 sachet, 2–3 times daily with or after meals, adjusted by the physician based on ammonia levels and clinical response |
| Digestive enzyme support / dyspepsia | 1 tablet or 1 sachet with each main meal, or as directed |
Pediatric Dose
Safety and efficacy of L-Ornithine L-Aspartate + Pancreatin in children are not well established; pediatric use should only occur under direct physician supervision (see Use in Special Populations).
Renal/Hepatic Adjustment
L-Ornithine L-Aspartate + Pancreatin should be used with caution and closer monitoring in patients with hepatic impairment (its primary use setting) and is contraindicated in severe renal failure (see Contraindications). No standardized dose-reduction schedule is established; dosing decisions should be individualized by the physician.
Side Effects of L-Ornithine L-Aspartate + Pancreatin
Most patients tolerate L-Ornithine L-Aspartate + Pancreatin well. Reported side effects include:
- Common: Nausea, vomiting, and other mild gastrointestinal upset, particularly at higher doses of the L-ornithine L-aspartate component.
- Uncommon: Hyperuricemia (elevated blood uric acid), usually asymptomatic and reversible on dose reduction or discontinuation.
- Rare: Hypersensitivity reactions such as skin rash, itching, or, rarely, more severe allergic reactions (see Contraindications).
Report any persistent or severe side effect to a physician promptly.
Contraindications of L-Ornithine L-Aspartate + Pancreatin
L-Ornithine L-Aspartate + Pancreatin is contraindicated in:
- Known hypersensitivity to L-ornithine L-aspartate, pancreatin, pork/beef-derived proteins (pancreatin is typically of porcine origin), or any other component of the formulation.
- Severe renal failure — due to the risk of increased nitrogen/ammonia load from the amino acid component.
- Acute pancreatitis — per product labeling for pancreatin-containing formulations.
Frequently Asked Questions about L-Ornithine L-Aspartate + Pancreatin
What is L-Ornithine L-Aspartate + Pancreatin used for?
L-Ornithine L-Aspartate + Pancreatin is used mainly in chronic liver disease to lower elevated blood ammonia levels (helpful in hyperammonemia and hepatic encephalopathy) and to support digestion through added pancreatic enzymes (amylase, lipase, protease) when the body's own enzyme output is reduced.
How should I take L-Ornithine L-Aspartate + Pancreatin?
L-Ornithine L-Aspartate + Pancreatin is usually taken with or immediately after meals, as tablets, sachets, or granules, exactly as directed by your physician. Do not crush or chew enteric-coated tablet forms, and do not skip doses.
Can L-Ornithine L-Aspartate + Pancreatin be used alone to treat hepatic encephalopathy?
No. L-Ornithine L-Aspartate + Pancreatin is a supportive/adjunct treatment. Hepatic encephalopathy requires comprehensive medical management, including treatment of underlying precipitating factors and other standard therapies, all directed by a physician.
Who should not take L-Ornithine L-Aspartate + Pancreatin?
L-Ornithine L-Aspartate + Pancreatin should not be used by anyone with known hypersensitivity to its components (including pork/beef-derived proteins from the pancreatin), by patients with severe renal failure, or during an acute episode of pancreatitis.
What are the common side effects of L-Ornithine L-Aspartate + Pancreatin?
The most common side effects are mild nausea, vomiting, or other gastrointestinal upset. Less commonly, L-Ornithine L-Aspartate + Pancreatin can raise blood uric acid levels (hyperuricemia). Rarely, allergic reactions such as rash or itching can occur. Tell your doctor if any side effect is severe or persistent.
Is L-Ornithine L-Aspartate + Pancreatin safe during pregnancy or breastfeeding?
Data are limited. L-Ornithine L-Aspartate + Pancreatin should be used during pregnancy or breastfeeding only if a physician determines it is clearly needed and the benefit outweighs any potential risk.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.